It is common finding within this vulnerable population occurring at about 30% to 50% among prevalent patients.2 In addition, sHPT can present early during the course of progressive CKD with parathyroid hormone (PTH) levels becoming elevated often before abnormalities in serum calcium or phosphate are detected. The gene discussed is PTH; the disease is chronic kidney disease.